In 1999, Fifteen Reports Suspended a Vaccine Within Weeks. The Spike Signal Has Waited Years for a Study.

In the fall of 1976, reports started reaching the CDC that unsettled the people reading them. Americans who had lined up for the swine flu shot were turning up with Guillain-Barré syndrome, an ascending paralysis that can put a healthy adult on a ventilator inside a week. Taken one at a time the cases were deniable, easy to write off as coincidence in a country that had just vaccinated more than 45 million people. The agency did not write them off. It investigated, tied the vaccine to an excess of roughly 11.7 Guillain-Barré cases per million vaccinated, and suspended the program.

A SIGNAL, THREE ERAS

Two vaccines came off fast on smaller signals; the spike-persistence question has sat since 2024. Source: CDC; Acta Dermato-Venereologica, 2026

Twenty-three years later the trigger was smaller. In 1999, fifteen reports to the Vaccine Adverse Event Reporting System of infants developing a bowel obstruction called intussusception after the RotaShield rotavirus vaccine were enough to suspend the recommendation within weeks. A national case-control study followed and confirmed the signal, roughly a 37-fold jump in risk in the three to seven days after the first dose, and RotaShield came off the market for good.

That is how a safety signal is supposed to move. It starts small and anecdotal, someone with authority decides it is worth a real look, and a controlled study either confirms it or clears it. Hold that sequence in mind, because a signal of roughly the same shape is on the table right now, and it is getting the opposite treatment.

A hypothesis, not a hashtag

The pattern picked up a nickname this year, “spikeopathy,” the idea that the spike protein itself, whether delivered by the virus or manufactured in your own cells after an mRNA shot, can act as a bioactive toxin long after everyone assumed it was gone. The label trended after TrialSite News walked through two striking cases and, to its credit, said so plainly in its own headline: they raise a serious hypothesis, they do not prove it. Strip the label off and the question underneath is simple. Will anyone with a budget actually test a biologically plausible injury pattern, or not?

The cases keeping the hypothesis alive are the kind clinicians once wrote up without anyone reaching for their political priors. In the journal Internal Medicine, a Japanese rehabilitation team described two men who lost the ability to swallow within a week of a Pfizer-BioNTech dose. The first, 24 years old, developed a facial palsy four days after his shot that spread into a cascade of cranial-nerve failures, with electromyography showing the nerves to his jaw, lips and tongue actively degenerating. The second, an 80-year-old whose Parkinson’s had been well controlled, was hospitalized with aspiration pneumonia and found to be silently inhaling thin liquid into his lungs. The authors are careful almost to a fault, stating flatly that causation could not be established and that VAERS cannot prove a link. Then they ran the database anyway: of 1,613,898 adverse-event reports filed to VAERS by late December 2024, 8,373 involved dysphagia, and in 73 percent of those the trouble began within ten days of the shot.

The clearance assumption is not holding up

The expectation, repeated all through the rollout, was that the spike protein and the genetic instructions to build it would be broken down and gone within days. Under a microscope that is not what pathologists keep finding. A team at University Hospital Tübingen, writing in Acta Dermato-Venereologica, took skin biopsies from patients with stubborn, delayed vasculitis and stained them for spike. They found it lodged in the endothelial cells lining the small blood vessels of those lesions as far out as 18 months after vaccination. A separate group reported the S1 fragment of spike sitting inside a class of immune cells called CD16+ monocytes for up to 245 days in people who tested negative for any prior COVID infection, which the authors read as vaccine-derived rather than left over from the virus.

SPIKE PERSISTENCE

18 monthsstill in vessel-lining cells after the shot

Spike protein found in the endothelial cells of vasculitic skin lesions this long after vaccination. Source: Acta Dermato-Venereologica, 2026

The endothelium matters because it is the single-cell lining of every blood vessel you own, and it is exquisitely sensitive to inflammation. A foreign protein parked in that lining for a year and a half is a biologically plausible trigger for inflammation in exactly the tissue where several of these injuries turn up. That is a mechanism, not a verdict. A mechanism is also the thing that separates a coincidence from a hypothesis a serious safety system is obligated to run down.

The same timing, across the whole body

The reports are not confined to one organ. Search the literature and the same timing, onset days to weeks after a dose, shows up across a startling range of tissues: reactive arthritis in 17 patients, optic neuropathy, pemphigus of the skin, Guillain-Barré syndrome, glomerular kidney disease, adult-onset Still’s disease, cranial-nerve palsies.

Any one of these, alone, is the kind of rare event that will happen somewhere in a population of hundreds of millions by pure chance. That is the honest counterargument, and it is a good one. But a real safety system does not ask whether a given injury ever happens after a shot. It asks whether the whole pattern happens more often than chance predicts. No case report, however vivid, can answer that. Only a controlled study can.

So has the study been done?

Not the one that would settle it, and the evidence that does exist cuts both ways. Spike persistence is real and now sits in peer-reviewed pathology. Yet at least one group tracking spike protein in patients’ blood over the long term found its lingering presence did not track with post-COVID symptoms, which works against the simplest version of the spikeopathy story. Case reports come without a denominator by construction. They cannot tell you how often the same injury strikes the unvaccinated, and without that number there is no risk to calculate. None of this makes the hypothesis wrong. It leaves it unresolved, and no one with the power to resolve it is trying.

In 1999, fifteen reports and a plausible mechanism bought a national case-control study inside a year. Today the mechanism is documented in human tissue, the adverse-event reports run into the thousands across a dozen organ systems, and the answer from the agencies that once moved on fifteen is a shrug and the phrase “correlation is not causation.” That phrase happens to be true. It is also, precisely, the argument for commissioning the study, not for refusing to. The same institutions that spent the pandemic calling these the most-studied products in medical history are, on this one specific and entirely answerable question, choosing not to look.

The tools to settle it already exist. The Tübingen staining protocol could be scaled into a controlled comparison, who carries persistent spike and who is sick, matched against the unvaccinated. What is missing is not a method but the will, and the will sits with the bodies that hold the budgets and the databases: the FDA, the CDC, the NIH. The tissue findings landed in 2024. Watch whether any of the three funds the prospective study that would turn spikeopathy into a settled yes or no, or whether another year passes with the question sitting exactly where it is. In 1976 and again in 1999, the system answered a question of this exact shape in a matter of months. This time the reports have been coming since 2021, the tissue findings since 2024, and no one in charge has started the clock.

In 1999, Fifteen Reports Suspended a Vaccine Within Weeks. The Spike Signal Has Waited Years for a Study.

A hypothesis, not a hashtag

The clearance assumption is not holding up

The same timing, across the whole body

So has the study been done?

Sources

Marcus Chen

In 1999, Fifteen Reports Suspended a Vaccine Within Weeks. The Spike Signal Has Waited Years for a Study.

A hypothesis, not a hashtag

The clearance assumption is not holding up

The same timing, across the whole body

So has the study been done?

Sources

Marcus Chen

Stories like this, every Sunday.

More to read

The FDA Is Fighting a Flesh-Eating Parasite We Eradicated in 1966 With a Flea Pill From 2000

A 2014 Trial Warned That Correcting Vaccine Fears Backfires on the Hesitant. Public Health Corrected Harder.

Rattlesnakes Carry Their Own Antivenom in Their Blood, and in Mice a Cocktail of It Beat CroFab Tenfold